"Prostatic Hyperplasia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both.
| Descriptor ID |
D011470
|
| MeSH Number(s) |
C12.294.565.500
|
| Concept/Terms |
Adenoma, Prostatic- Adenoma, Prostatic
- Adenomas, Prostatic
- Prostatic Adenomas
- Prostatic Adenoma
|
Below are MeSH descriptors whose meaning is more general than "Prostatic Hyperplasia".
Below are MeSH descriptors whose meaning is more specific than "Prostatic Hyperplasia".
This graph shows the total number of publications written about "Prostatic Hyperplasia" by people in this website by year, and whether "Prostatic Hyperplasia" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 1 | 1 | 2 |
| 2007 | 1 | 0 | 1 |
| 2008 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2015 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Prostatic Hyperplasia" by people in Profiles.
-
Comparison of GreenLight laser and transurethral resection of the prostate baseline characteristics and outcomes: lessons learned from the Clinical Research Office of the Endourological Society GreenLight Laser Study. Minerva Urol Nefrol. 2017 Jun; 69(3):285-292.
-
Reply: To PMID 26276574. Urology. 2015 Oct; 86(4):726.
-
National Trends of Simple Prostatectomy for Benign Prostatic Hyperplasia With an Analysis of Risk Factors for Adverse Perioperative Outcomes. Urology. 2015 Oct; 86(4):721-5.
-
Labda-8(17),12,14-trien-19-oic acid contained in fruits of Cupressus sempervirens suppresses benign prostatic hyperplasia in rat and in vitro human models through inhibition of androgen and STAT-3 signaling. Phytother Res. 2014 Aug; 28(8):1196-203.
-
The associations between statin use and prostate cancer screening, prostate size, high-grade prostatic intraepithelial neoplasia (PIN), and prostate cancer. Cancer Causes Control. 2011 Mar; 22(3):417-26.
-
Intravesical protrusion of the prostate as a predictive method of bladder outlet obstruction. Int Braz J Urol. 2008 Sep-Oct; 34(5):627-33; discussion 634-7.
-
Decreased efficiency of potassium-titanyl-phosphate laser photoselective vaporization prostatectomy with long-term 5 alpha-reductase inhibition therapy: is it true? Urology. 2007 Nov; 70(5):927-30.
-
Delay in the progression of low-risk prostate cancer: rationale and design of the Reduction by Dutasteride of Clinical Progression Events in Expectant Management (REDEEM) trial. Contemp Clin Trials. 2007 Nov; 28(6):763-9.
-
The association between body size, prostate volume and prostate-specific antigen. Prostate Cancer Prostatic Dis. 2007; 10(2):137-42.
-
Effects of obesity and height on prostate-specific antigen (PSA) and percentage of free PSA levels among African-American and Caucasian men. Cancer. 2006 Nov 15; 107(10):2361-7.